BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22897844)

  • 21. c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma.
    Scheller H; Tobollik S; Kutzera A; Eder M; Unterlehberg J; Pfeil I; Jungnickel B
    Oncogene; 2010 Feb; 29(6):888-97. PubMed ID: 19881537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
    Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.
    Kuttler F; Amé P; Clark H; Haughey C; Mougin C; Cahn JY; Dang CV; Raffeld M; Fest T
    Oncogene; 2001 Sep; 20(42):6084-94. PubMed ID: 11593416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma.
    Wang WG; Liu ZB; Jiang XN; Lee J; Zhou XY; Li XQ
    Histopathology; 2017 Nov; 71(5):778-785. PubMed ID: 28639315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reply to Hart et al.: MINCR and MYC: More than expression correlation.
    Doose G; Hoffmann S; Iaccarino I
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E498. PubMed ID: 26811501
    [No Abstract]   [Full Text] [Related]  

  • 26. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
    Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
    Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer: two in one.
    Berns A
    Nature; 2005 Aug; 436(7052):787-9. PubMed ID: 16094355
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
    Broecker-Preuss M; Becher-Boveleth N; Bockisch A; Dührsen U; Müller S
    J Transl Med; 2017 Jul; 15(1):158. PubMed ID: 28724379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis in Burkitt lymphoma cells is driven by c-myc.
    Milner AE; Grand RJ; Waters CM; Gregory CD
    Oncogene; 1993 Dec; 8(12):3385-91. PubMed ID: 8247541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
    Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.
    Doose G; Haake A; Bernhart SH; López C; Duggimpudi S; Wojciech F; Bergmann AK; Borkhardt A; Burkhardt B; Claviez A; Dimitrova L; Haas S; Hoell JI; Hummel M; Karsch D; Klapper W; Kleo K; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Lenze D; Loeffler M; Mantovani-Löffler L; Möller P; Ott G; Richter J; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schneider M; Scholz I; Stilgenbauer S; Stunnenberg HG; Szczepanowski M; Trümper L; Weniger MA; ; Hoffmann S; Siebert R; Iaccarino I
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5261-70. PubMed ID: 26351698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
    Klein G
    AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Myc inhibition negatively impacts lymphoma growth.
    Gomez-Curet I; Perkins RS; Bennett R; Feidler KL; Dunn SP; Krueger LJ
    J Pediatr Surg; 2006 Jan; 41(1):207-11; discussion 207-11. PubMed ID: 16410134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma.
    Smith SM; Anastasi J; Cohen KS; Godley LA
    Blood Cells Mol Dis; 2010 Dec; 45(4):317-23. PubMed ID: 20817505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
    van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
    Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.
    Kretzmer H; Bernhart SH; Wang W; Haake A; Weniger MA; Bergmann AK; Betts MJ; Carrillo-de-Santa-Pau E; Doose G; Gutwein J; Richter J; Hovestadt V; Huang B; Rico D; Jühling F; Kolarova J; Lu Q; Otto C; Wagener R; Arnolds J; Burkhardt B; Claviez A; Drexler HG; Eberth S; Eils R; Flicek P; Haas S; Humme M; Karsch D; Kerstens HHD; Klapper W; Kreuz M; Lawerenz C; Lenzek D; Loeffler M; López C; MacLeod RAF; Martens JHA; Kulis M; Martín-Subero JI; Möller P; Nage I; Picelli S; Vater I; Rohde M; Rosenstiel P; Rosolowski M; Russell RB; Schilhabel M; Schlesner M; Stadler PF; Szczepanowski M; Trümper L; Stunnenberg HG; Küppers R; Ammerpohl O; Lichter P; Siebert R; Hoffmann S; Radlwimmer B
    Nat Genet; 2015 Nov; 47(11):1316-1325. PubMed ID: 26437030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.